MAPT and Brain atrophy: Structural magnetic resonance imaging (MRI) has been used to study effects of other CSF biomarkers on brain atrophy, including Aβ42 and tau [17,18], but to our knowledge no study has explored effects of CSF α-synuclein on brain atrophy.